All News Tuoxin Pharmaceutical Group Co.,Ltd.

Equities

301089

CNE100004YC3

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-06-06 EDT			5-day change	1st Jan Change
32.09 ^CNY	+1.97%		-7.92%	-40.59%

05-14	Tuoxin Pharmaceutical Group Co.,Ltd. Elects Lin Xiansheng and Yang Shaohua as Non-Independent Directors	CI
04-22	Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Tuoxin Pharmaceutical Group Co.,Ltd. Approves 2023 Profit Distribution Plan	05-14	CI
Tuoxin Pharmaceutical Group Co.,Ltd. Elects Lin Xiansheng and Yang Shaohua as Non-Independent Directors	05-14	CI
Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22	CI
Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-22	CI
Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Tuoxin Pharmaceutical Group Co.,Ltd.(XSEC:301089) added to S&P Global BMI Index	23-09-18	CI
Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Approves the Cash Dividend for the Year 2022, Payment Date: 06 June 2023	23-05-31	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. has Changed its Name to Tuoxin Pharmaceutical Group Co., Ltd	23-05-26	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Approves the Cash Dividend for the Year 2022	23-05-18	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year of 2022	23-04-26	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25	CI
Xinxiang Tuoxin Pharma to Form New Chemical Products Subsidiary	23-03-17	MT
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-20	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-22	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2021, Payable on May 25, 2022	22-05-18	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2021	22-05-17	CI
Tuoxin Pharmaceutical to Free Up 1.5 Million Shares For Trading; Shares Tank 5%	22-04-26	MT
Xinxiang Tuoxin Pharma’s 2021 Profit Plunges 42% as Sales Slip 5%	22-04-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Tuoxin Pharmaceutical Group Co.,Ltd.

Equities

301089

CNE100004YC3

All News

Filters